Company News

As 2026 begins, bioMérieux proudly continues our tradition of looking into the next twelve months and analyzing how key food safety trends will influence the food supply chain and our partners’ operations. The three identified trends for 2026 will continue to develop and inform food safety and quality standards — standards that we at bioMérieux are proud to help pioneer and contribute to.

bioMérieux recently launched IDEA™ STEC, an advanced Immuno Detection Evolution Agar designed to simplify and enhance the confirmation step in the detection of Shigatoxin-producing E. Coli.

In the relentless pursuit of healthcare efficiency and better patient care, one truth is becoming increasingly clear: diagnostics are not just clinical tools—they are economic engines.

bioMérieux has just acquired a stake in Allergen Alert, an innovative startup specializing in the rapid detection of food allergens for individuals and professionals.

bioMérieux confirms its ethical commitment to clinical research through a Bioethics Charter that guarantees transparency, accountability, and respect for human dignity. In particular, it aims to protect research participants when collecting and using biological samples and personal data.